Regeneron Pharmaceuticals, Inc.
Regeneron Pharmaceuticals, Inc. (REGN) — Form 144: Proposed sale of shares
AI-generated summary
Director GEORGE L. SING filed a notice of proposed sale for 1,000 shares of Common stock with an aggregate market value of $960,264.40 through Morgan Stanley Smith Barney LLC Executive Financial Services. The sale is approximated to occur on November 16, 2026. The shares were originally acquired on April 9, 1991, through a private acquisition from the issuer or affiliate.
Key facts
- Seller
- GEORGE L. SING
- Relationship
- Director
- Shares to sell
- 1,000
- Market value
- $960,264.40
- Approximate sale date
- Nov 16, 2026
- Broker
- Morgan Stanley Smith Barney LLC Executive Financial Services
- Acquired
- Apr 9, 1991 · Private Acquisition from Issuer/Affiliate
More REGN filings
- S-8
Filed Nov 19, 2026
- 4
Filed Nov 18, 2026
- 4
Filed Nov 18, 2026
- 4
Filed Nov 18, 2026
- 144
Filed Nov 17, 2026
- 144
Filed Nov 17, 2026
Not investment advice. Summaries can contain errors; the SEC filing is the official record.